• Female researcher examining a test tube during research of additional potential cancer application for OncoVAX immunotherapy.

Data from previous studies indicate OncoVAX® may have potential utility against other solid tumors including renal cell carcinoma and melanoma. Vaccinogen is currently researching methods to expand its reach into these and other tumors, because unlike a drug tailored to one disease, OncoVAX® is a process which may be applied to many cancers.